FILLMED® M-HA 10
$109.00
FILLMED® M-HA 10 is a sterile, viscoelastic solution of non-crosslinked hyaluronic acid. Designed for mesotherapy or superficial injections to deeply hydrate the skin, improve elasticity, restore radiance, and soften fine superficial lines. For professional use only.
Product Overview: FILLMED® M-HA 10
FILLMED® M-HA 10 is a CE-marked, sterile, transparent, and viscoelastic solution containing a high concentration of pure, non-crosslinked hyaluronic acid (10mg/ml). Produced by Fillmed Laboratoires (formerly Filorga Laboratoires), this product is designed for superficial intradermal injections or mesotherapy techniques to improve skin hydration, tone, elasticity, and overall quality.
It is indicated for addressing skin dehydration, loss of radiance, reduced elasticity, and the appearance of very fine superficial lines, particularly in areas such as the face, neck, décolleté, and hands.
Note: This skin revitalization product should only be administered by qualified healthcare professionals trained in superficial injection or mesotherapy techniques.
Mechanism of Action and Properties
FILLMED® M-HA 10 works primarily through the hydrating and biorevitalizing properties of its non-crosslinked hyaluronic acid. When injected into the superficial layers of the skin, the HA has a high capacity to attract and bind water molecules, leading to intense and lasting hydration of the dermis. This increased hydration helps to plump the skin, improve its suppleness, and restore a healthy glow. Furthermore, hyaluronic acid is known to create a favorable environment for fibroblast activity, potentially stimulating the production of new collagen and elastin, thereby improving skin firmness and elasticity over time.
Unlike cross-linked dermal fillers designed for significant volume restoration, M-HA 10 focuses on improving the intrinsic quality and hydration level of the skin.
Indications and Treatment Protocol
FILLMED® M-HA 10 is indicated for individuals seeking to address:
- Skin dehydration and dryness
- Dull or lackluster complexion
- Loss of skin elasticity and suppleness
- Very fine superficial lines and wrinkles (e.g., “smoker’s lines” on the surface, fine crow’s feet)
- Improvement of overall skin texture and tone
Common treatment areas include the face (including perioral and periocular areas for superficial lines), neck, décolletage, and the back of the hands. A typical treatment protocol may involve an initial series of 3 sessions spaced approximately 2-4 weeks apart, followed by maintenance sessions every 3-6 months, as determined by the practitioner based on skin condition and patient response.
Administration is performed via microinjections into the superficial dermis or dermo-epidermal junction.
Expected Outcomes
Following a recommended treatment course, anticipated outcomes include:
- Significantly improved skin hydration and moisture levels
- Enhanced skin radiance and a brighter complexion
- Increased skin elasticity, suppleness, and firmness
- Softening of very fine superficial lines
- Improved overall skin texture and a more youthful appearance
Potential Adverse Events
As with any superficial injection or mesotherapy procedure, patients may experience temporary reactions primarily related to the injections. Practitioners should advise patients on potential side effects:
- Common Reactions (Typically Mild and Transient): Small punctate marks, erythema (redness), mild swelling or bruising (hematomas) at injection points, slight itching, burning sensation, or tenderness. These generally resolve within a few hours to a few days.
- Less Common/Rare Reactions: Persistent irritation, inflammation, infection (if aseptic techniques are not strictly followed), allergic/hypersensitivity reactions (rare for pure HA, but always a possibility), skin discoloration, nodule formation (granuloma – very rare with non-crosslinked HA).
Patients should be instructed to report any persistent, severe, or concerning reactions to their practitioner promptly.
Storage Conditions
Store according to manufacturer’s recommendations, typically between 2°C and 25°C, protected from light and freezing. Ensure the vial integrity before use. Once opened, use immediately and discard any unused portion.
Disclaimer: This overview provides general information. Healthcare professionals must consult the full instructions provided with FILLMED® M-HA 10 before administration for comprehensive details regarding product composition, indications, contraindications, warnings, precautions, administration techniques, and potential adverse events.
Active Substance(s) | Hyaluronic acid |
---|---|
Strength | 10 mg/ml |
Pack Size | 3-3ml pre-filled syringes |